PCN140 IMPACT OF TUMOR RESPONSE ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED WITH VELCADE/MELPHALAN/PREDNISONE (V-MP): RESULTS FROM THE VISTA TRIAL

✍ Scribed by J Meunier; A Regnault; D Robinson; K Rosa; JF San Miguel; H van de Velde; PG Richardson; A Cakana; R Dhawan

• Book ID: 118611982
• Publisher: John Wiley and Sons
• Year: 2009
• Tongue: English
• Weight: 82 KB
• Volume: 12
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/s1098-3015(10)74390-4